Back to the Top 100
Abridge logo

Rank 14AI & Clinical Intelligence

Abridge

Generates real-time clinical documentation and structured data from patient-clinician conversations using proprietary generative AI.

Visit website
Signal Score
91.8
Total raised
$212M
Stage
Series C
Founded
2018
Headquarters
Pittsburgh, USA
Region
North America

Their signal

Abridge leads the documentation space with massive health system deployments, landmark Epic integration, and a major $150M Series C round validating its enterprise-scale conversational AI technology.

Signal Score 91.8editorial estimate, see how it is built
Capital (25% weight)92

Total raised, quality of investors and recency of the last round.

Growth (25% weight)95

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)88

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)90

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)93

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in AI & Clinical Intelligence

ShareLink copied

Did we miss something?

Change, add or remove details on this company. Our desk reviews every request.

Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.